(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Lexicon Pharmaceuticals, Inc. | ||||||||
Date: April 1, 2021 | By: | /s/ Brian T. Crum | ||||||
Brian T. Crum | ||||||||
Vice President and General Counsel |
Cover |
Mar. 29, 2021 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Mar. 29, 2021 |
Entity Registrant Name | Lexicon Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 000-30111 |
Entity Tax Identification Number | 76-0474169 |
Entity Address, Address Line One | 8800 Technology Forest Place |
Entity Address, City or Town | The Woodlands |
Entity Address, State or Province | TX |
Entity Address, Postal Zip Code | 77381 |
City Area Code | 281 |
Local Phone Number | 863-3000 |
Title of 12(b) Security | Common Stock, par value $0.001 |
Trading Symbol | LXRX |
Security Exchange Name | NASDAQ |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001062822 |
Amendment Flag | false |
O!Y)OKM:IU3UQN'G/RK'4DF8HR#/# QH-W 9;+8VKTJU _IF%'B6O.OV%H ME;4']%UH4YU9)LE?(CVZ9AL4>[UV'ULG0;5'!+C+%W4'+&4F9(:],YIS\[%_X/IJ^:HL(XHX\ M-?P\A/1PL,KM5R-7$7R2?ETNZY=B@UXC6>7L%'?A_Y'=9UD.9(V N&PCX,&G M^TG^?IMPLW+U_ 0*-G:3+66JUB\:!!O1*GNGN#OOT":0-@/V>@\9VY#/O!X* MEP);#?PN[5.*D55^3W&K'D,IHZ*<=Y*M:GEP@:-)\@X.@^Y@#0<'*$M&)%^" MD'_1 [,VV[/JMF-U6IP/%]K":;-HQG"^Y\:] ,^76MM]QQTYR_\8C/X#4$L# M!!0 ( (Z$@5*?H!OPL0( .(, - >&PO
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end
S:>#ELY5#W5?.NQX<:]%